PYXS · Pyxis Oncology, Inc.
$3.23
-0.09 (-2.71%)
At close · Aug 28
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern for one year from the date these unaudited condensed consolidated financial statements were issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$276.08M
Shares
83.41M
Pyxis Oncology, Inc. Earnings Call Transcripts
Quarterly earnings calls for Pyxis Oncology, Inc. (PYXS), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Conference
Investor event
2026-06-04
Pyxis Oncology, Inc. (PYXS) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-20
Pyxis Oncology, Inc. (PYXS) Q1 2026 Earnings Call
Diluted EPS
$-0.37
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-09-09
Pyxis Oncology, Inc. (PYXS) Q2 2025 Earnings Call
Revenue
$2.82M
Diluted EPS
$-0.30
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-29
Pyxis Oncology, Inc. (PYXS) Q4 2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–4 of 4 earnings calls
Key facts
CIK
1782223
CUSIP
747324101
13F (30d)
74 filings
72 filers
Visit website
Investor relations